Cargando…
BRAF(V600E) mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features
BACKGROUND: The incidence of thyroid cancer is increasing worldwide. This study investigated the association of B-type RAF kinase (BRAF)(V600E) mutation status, the expression of BRAF-activated long non-coding RNA (BANCR) and microRNA miR-9, and the clinicopathological features of papillary thyroid...
Autores principales: | Shi, Chenlei, Cao, Jia, Shi, Tiefeng, Liang, Meihua, Ding, Chao, Lv, Yichen, Zhang, Weifeng, Li, Chuanle, Gao, Wenchao, Wu, Gang, Man, Jianting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321545/ https://www.ncbi.nlm.nih.gov/pubmed/32593310 http://dx.doi.org/10.1186/s12957-020-01923-7 |
Ejemplares similares
-
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAF(V600E) Mutational Status and Expression of Angiogenic Factors
por: Shi, Chenlei, et al.
Publicado: (2016) -
The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors
por: Choi, Sun Yi, et al.
Publicado: (2013) -
Association between BRAF(V600E) mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
por: Lu, Hai-Zhen, et al.
Publicado: (2017) -
Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013) -
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)